• Aydemir, M. N., Aydemir, H. B., Korkmaz, E. M., Budak, M., Cekin, N., Pinarbasi, E., 2021. Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways. Gene Rep. 22, 101012.

  • Bartel, D. P., 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.

  • Bellare, P., Ganem, D., 2009. Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe 6, 570-575.

  • Fu, Z., Wang, J., Wang, Z., Sun, Y., Wu, J., Zhang, Y., Liu, X., Zhou, Z., Zhou, L., Zhang, C. Y., Yi, Y., Xia, X., Wang, L., Chen, X., 2021. A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease. Cell Discov. 7, 48.

  • Grillo, F., Barisione, E., Ball, L., Mastracci, L., Fiocca, R., 2021. Lung fibrosis: an undervalued finding in COVID-19 pathological series. Lancet Infect. Dis. 21, e72.

  • Ha, M., Kim, V. N., 2014. Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol. 15, 509-524.

  • Halim, F. S., Parmin, N. A., Hashim, U., Gopinath, S. C. B., Dahalan, F. A., Zakaria, I. I., Ang, W. C., Jaapar, N. F., 2022. MicroRNA of N-region from SARS-CoV-2: potential sensing components for biosensor development. Biotechnol. Appl. Biochem. 69, 1696-1711.

  • Han, X., Fan, Y., Alwalid, O., Li, N., Jia, X., Yuan, M., Li, Y., Cao, Y., Gu, J., Wu, H., Shi, H., 2021. Six-month follow-up chest CT findings after severe COVID-19 pneumonia. Radiology 299, E177-E186.

  • Harwig A., Das A.T., Berkhout B., 2014. Retroviral microRNAs. Curr. Opin. Virol. 7, 47-54.

  • Hill C., Jones M. G., Davies D. E., Wang Y., 2019. Epithelial-mesenchymal transition contributes to pulmonary fibrosis via aberrant epithelial/fibroblastic cross-talk. J. Lung Health Dis. 3, 31-35.

  • Huang, W. J., Tang, X. X., 2021. Virus infection induced pulmonary fibrosis. J. Transl. Med. 19, 496.

  • Jeon, S., Jin, H., Kim, J. M., Hur, Y., Song, E. J., Lee, Y. J., Na, Y., Cho, J., Lee, Y. S., 2023. The miR-15b-Smurf2-HSP27 axis promotes pulmonary fibrosis. J. Biomed. Sci. 30, 2.

  • Kim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., Sheppard, D., Chapman, H. A., 2006. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc. Natl. Acad. Sci. USA. 103, 13180-13185.

  • Li, X., Fu, Z., Liang, H., Wang, Y., Qi, X., Ding, M., Sun, X., Zhou, Z., Huang, Y., Gu, H., Li, L., Chen, X., Li, D., Zhao, Q., Liu, F., Wang, H., Wang, J., Zen, K., Zhang, C. Y., 2018. H5N1 influenza virus-specific miRNA-like small RNA increases cytokine production and mouse mortality via targeting poly(rC)-binding protein 2. Cell Res. 28, 157-171.

  • Liu, Z., Wang, J., Ge, Y., Xu, Y., Guo, M., Mi, K., Xu, R., Pei, Y., Zhang, Q., Luan, X., Hu, Z., Chi, Y., Liu, X., 2021. SARS-CoV-2 encoded microRNAs are involved in the process of virus infection and host immune response. J. Biomed. Res. 35, 216-227.

  • Liu, Z., Wang, J., Xu, Y., Guo, M., Liu, X., 2020. Implications of the virus-encoded miRNA and host miRNA in the pathogenicity of SARS-CoV-2. arXiv: 2004.04874.

  • Lu, X. Y., Chen, D., Gu, X. Y., Ding, J., Zhao, Y. J., Zhao, Q., Yao, M., Chen, Z., He, X. H., Cong, W. M., 2017. Predicting value of ALCAM as a target gene of microRNA-483-5p in patients with early recurrence in hepatocellular carcinoma. Front. Pharmacol. 8, 973.

  • Manichaikul, A., Wang, X. Q., Sun, L., Dupuis, J., Borczuk, A. C., Nguyen, J. N., Raghu, G., Hoffman, E. A., Onengut-Gumuscu, S., Farber, E. A., Kaufman, J. D., Rabinowitz, D., Stukovsky, K. D. H., Kawut, S. M., Hunninghake, G. M., Washko, G. R., O'Connor, G. T., Rich, S. S., Barr, R. G., Lederer, D. J., 2017. Genome-wide association study of subclinical interstitial lung disease in MESA. Respir. Res. 18, 97.

  • Meng, F., Siu, G. K., Mok, B. W., Sun, J., Fung, K. S. C., Lam, J. Y., Wong, N. K., Gedefaw, L., Luo, S., Lee, T. M. H., Yip, S. P., Huang, C. L., 2021. Viral MicroRNAs encoded by nucleocapsid gene of SARS-CoV-2 are detected during infection, and targeting metabolic pathways in host cells. Cells 10, 1762.

  • Merino, G. A., Raad, J., Bugnon, L. A., Yones, C., Kamenetzky, L., Claus, J., Ariel, F., Milone, D. H., Stegmayer, G., 2021. Novel SARS-CoV-2 encoded small RNAs in the passage to humans. Bioinformatics 36, 5571-5581.

  • Mo, X., Jian, W., Su, Z., Chen, M., Peng, H., Peng, P., Lei, C., Chen, R., Zhong, N., Li, S., 2020. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur. Respir. J. 55, 2001217.

  • Morales, L., Oliveros, J. C., Fernandez-Delgado, R., tenOever, B. R., Enjuanes, L., Sola, I., 2017. SARS-CoV-Encoded small RNAs contribute to infection-associated lung pathology. Cell Host Microbe 21, 344-355.

  • Nagaraja, S. S., Nagarajan, D., 2018. Radiation-induced pulmonary epithelial-mesenchymal transition: a review on targeting molecular pathways and mediators. Curr. Drug Targets 19, 1191-1204.

  • Pfeffer, S., Zavolan, M., Grasser, F. A., Chien, M., Russo, J. J., Ju, J., John, B., Enright, A. J., Marks, D., Sander, C., Tuschl, T., 2004. Identification of virus-encoded microRNAs. Science 304, 734-736.

  • Ray, I., Michael, A., Meira, L. B., Ellis, P. E., 2023. The role of cytokines in epithelial-mesenchymal transition in gynaecological cancers: a systematic review. Cells 12, 416.

  • Salton F., Volpe M. C., Confalonieri M., 2019. Epithelial-mesenchymal transition in the pathogenesis of idiopathic pulmonary fibrosis. Medicina (Kaunas) 55, 83.

  • She, Y. X., Yu, Q. Y., & Tang, X. X., 2021. Role of interleukins in the pathogenesis of pulmonary fibrosis. Cell Death Discov. 7, 52.

  • Sheng, G., Chen, P., Wei, Y., Yue, H., Chu, J., Zhao, J., Wang, Y., Zhang, W., Zhang, H. L., 2020. Viral infection increases the risk of idiopathic pulmonary fibrosis: a meta-analysis. Chest 157, 1175-1187.

  • Sisto M., Lisi S., 2024. Special issue “molecular mechanism in epithelial-mesenchymal transition (EMT) and fibrosis”. Int. J. Mol. Sci. 25, 3808.

  • Song, Q., Xu, Y., Yang, C., Chen, Z., Jia, C., Chen, J., Zhang, Y., Lai, P., Fan, X., Zhou, X., Lin, J., Li, M., Ma, W., Luo, S., Bai, X., 2014. miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM. Cancer Res. 74, 3031-3042.

  • Veres-Szekely, A., Pap, D., Sziksz, E., Javorszky, E., Rokonay, R., Lippai, R., Tory, K., Fekete, A., Tulassay, T., Szabo, A. J., Vannay, A., 2017. Selective measurement of alpha smooth muscle actin: why beta-actin can not be used as a housekeeping gene when tissue fibrosis occurs. BMC Mol. Biol. 18, 12.

  • Wang, D., Liu, Z., Yan, Z., Liang, X., Liu, X., Liu, Y., Wang, P., Bai, C., Gu, Y., Zhou, P. K., 2021. MiRNA-155-5p inhibits epithelium-to-mesenchymal transition (EMT) by targeting GSK-3beta during radiation-induced pulmonary fibrosis. Arch. Biochem. Biophys. 697, 108699.

  • Weidle, U. H., Eggle, D., Klostermann, S., Swart, G. W., 2010. ALCAM/CD166: cancer-related issues. Cancer Genomics Proteomics 7, 231-243.

  • Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., Tai, Y., Bai, C., Gao, T., Song, J., Xia, P., Dong, J., Zhao, J., Wang, F. S., 2020. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 8, 420-422.

  • Yu, M., Liu, Y., Xu, D., Zhang, R., Lan, L., Xu, H., 2020. Prediction of the development of pulmonary fibrosis using serial thin-section CT and clinical features in patients discharged after treatment for COVID-19 pneumonia. Korean J. Radiol. 21, 746-755.

  • Zhang, S., Amahong, K., Sun, X., Lian, X., Liu, J., Sun, H., Lou, Y., Zhu, F., Qiu, Y., 2021. The miRNA: a small but powerful RNA for COVID-19. Briefings Bioinf. 22, 1137-1149.

  • Zhao, Q., Wang, Q., Zhao, B., Wang, Y., Lu, J., Guo, Y., Zhu, X., Qian, L., Yu, S., Hao, L., Liu, Z., Yu, Z., 2022. Identification of a SARS-CoV-2 virus-encoded small non-coding RNA in association with the neurological disorders in COVID-19 patients. Signal Transduct. Targeted Ther. 7, 107.

  • Zhu, Y., Zhang, Z., Song, J., Qian, W., Gu, X., Yang, C., Shen, N., Xue, F., Tang, Y., 2021. SARS-CoV-2-Encoded MiRNAs inhibit host type I interferon pathway and mediate allelic differential expression of susceptible gene. Front. Immunol. 12, 767726.